The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons

被引:257
作者
Adelsberger, H
Quasthoff, S
Grosskreutz, J
Lepier, A
Eckel, F
Lersch, C
机构
[1] Univ Munich, Inst Zool, D-80333 Munich, Germany
[2] Graz Univ, Neurol Klin, A-8036 Graz, Austria
[3] Tech Univ Munich, Inst Physiol, D-80802 Munich, Germany
[4] Tech Univ Munich, Med Klin 2, D-81675 Munich, Germany
关键词
neuropathy; colorectal cancer; dorsal root ganglia; hippocampal neuron; sural nerve;
D O I
10.1016/S0014-2999(00)00667-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The chemotherapeutic oxaliplatin causes a sensory-motor neuropathy with predominantly hyperpathic symptoms. The mechanism underlying this hyperexcitability was investigated using rat sensory nerve preparations, dorsal root ganglia and hippocampal neurons. Oxaliplatin resulted in an increase of the amplitude and duration of compound action potentials. It lengthened the refractory period of peripheral nerves suggesting an interaction with voltage-gated Na+ channels. Application of oxaliplatin to dorsal root ganglion neurons resulted in an increase of the Na+ current, a block of the maximal amplitude and a shift of the voltage-response relationship towards more negative membrane potentials. The effect was detectable on 13 of 18 tested cells. This observation, together with the absence of any effect on Na+ currents of hippocampal neurons, suggests that the interaction of oxaliplatin is restricted to one or more channel subtypes. The effect of oxaliplatin could be antagonised by the Na+ channel blocker carbamazepine which could be used to reduce side effects of oxaliplatin therapy in patients. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 23 条
  • [1] ADELSBERGER H, 1999, BIOL CHEM S, V380, pS132
  • [2] BAKER M, 1987, J PHYSIOL-LONDON, V383, P45
  • [3] Becouarn Y, 1998, SEMIN ONCOL, V25, P23
  • [4] Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs
    Black, JA
    DibHajj, S
    McNabola, K
    Jeste, S
    Rizzo, MA
    Kocsis, JD
    Waxman, SG
    [J]. MOLECULAR BRAIN RESEARCH, 1996, 43 (1-2): : 117 - 131
  • [5] BOSTOCK H, 1983, J PHYSIOL-LONDON, V313, P301
  • [6] BOUGHATTAS N, 1994, P AM ASSOC CANC RES, V35, P2583
  • [7] Cummins TR, 1997, J NEUROSCI, V17, P3503
  • [8] NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy
    Dib-Hajj, SD
    Tyrrell, L
    Black, JA
    Waxman, SG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8963 - 8968
  • [9] PHASE-I STUDY OF OXALIPLATIN IN PATIENTS WITH ADVANCED CANCER
    EXTRA, JM
    ESPIE, M
    CALVO, F
    FERME, C
    MIGNOT, L
    MARTY, M
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (04) : 299 - 303
  • [10] Extra JM, 1998, SEMIN ONCOL, V25, P13